News – Page 28 – Endpoints News

GSK to research whether shingles vaccine can cut dementia risk

2 months ago

Another immunology biotech emerges as Hillstar takes flight with $67M

2 months ago

Merck strikes deal for heart drug, worth up to $2B, with China’s Hengrui

2 months ago

Trump taps acting CDC chief Susan Monarez for permanent role

2 months ago

Three major questions on pharma tariffs Trump claims are on the way

2 months ago

AbbVie files trade secrets suit against ADC competitor

2 months ago

FDA's biologics chief stresses need for vaccine transmission data despite high costs to generate

2 months ago

Two biotechs fail to beat or match Regeneron's Eylea in key trials

2 months ago

Surrozen raises $175M, to focus on ophthalmology; CBC Group has a new $1B fund

2 months ago

Novo Nordisk pays $200M upfront for China-based biotech’s triple-G obesity shot

2 months ago

Biogen plans to open new headquarters in Boston area in 2028

2 months ago

Tempero Bio, led by ex-Novartis execs, gets $70M to reduce substance use disorders

2 months ago

23andMe files for bankruptcy, CEO Wojcicki steps down

2 months ago

Belgian biotech Augustine gets $85M for neuro and cardiometabolic pills

2 months ago

Teenager dies after receiving Sarepta therapy; Immunovant gets Phase 3 win, but shifts focus; Alnylam’s big moment; ...

2 months ago

Liver cancer drug combo gets second FDA rejection over manufacturing issues

2 months ago

Trump think tank resurrects international drug pricing model to go after 'global freeloading'

2 months ago

Alnylam hopes its broad ATTR-CM label can give Amvuttra an edge in heart disease

2 months ago

BARDA cancels annual biomedical event for industry, government reps

2 months ago

The buildup to Chimerix's $935M exit to Jazz, with more than half a dozen parties intrigued

2 months ago

FDA approves Novartis’ Fabhalta in another rare kidney disease

2 months ago

Genfit's up to €185M royalty deal; J&J’s Tremfya gets a Crohn's approval

2 months ago

AstraZeneca puts $2.5B toward first vaccine factory and second R&D site in China

2 months ago

AstraZeneca broadens presence in China, promising $8B+ to Harbour and Syneron

2 months ago

First page Previous page 25 26 272829 30 31 Next page Last page